Krishnaswamy Madhavan

4 Gy versus 24 Gy radiotherapy for patients with indolent lymphoma (FORT): a randomised phase 3 non-inferiority trial

Peter Hoskin, Amy A. Kirkwood, Bilyana Popova et al. · The Lancet Oncology · 2014 · 244 citations

Medicine, Oncology, Radiation Oncology +7

Effect of Single-Fraction vs Multifraction Radiotherapy on Ambulatory Status Among Patients With Spinal Canal Compression From Metastatic Cancer

Peter Hoskin, Kirsten Hopkins, Vivek Misra et al. · JAMA · 2019 · 118 citations · Full text

Medicine, Oncology, Radiation Oncology +16

4 Gy versus 24 Gy radiotherapy for follicular and marginal zone lymphoma (FoRT): long-term follow-up of a multicentre, randomised, phase 3, non-inferiority trial

Peter Hoskin, B. Popova, Oliver Schofield et al. · The Lancet Oncology · 2021 · 108 citations · Full text

Medicine, Oncology, Radiation Oncology +8

Study protocol for a randomised controlled trial of brief, habit-based, lifestyle advice for cancer survivors: exploring behavioural outcomes for the Advancing Survivorship Cancer Outcomes Trial (ASCOT)

Rebecca J. Beeken, Helen Croker, Maggie Heinrich et al. · BMJ Open · 2016 · 44 citations · Full text

Nursing, Health Promotion, Oncology +16

Thyroidectomy with or without postoperative radioiodine for patients with low-risk differentiated thyroid cancer in the UK (IoN): a randomised, multicentre, non-inferiority trial

Ujjal K. Mallick, Kate Newbold, Matthew Beasley et al. · The Lancet · 2025 · 36 citations · Full text

Medicine, Oncology, Surgery +11